Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy in head and neck cancer.

× No keyword cloud information.

16 in total

1. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

Authors: A Chahlavi; T Todo; R L Martuza; S D Rabkin
Journal: Neoplasia Date: 1999-06 Impact factor: 5.715

2. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma.

Authors: J V Salvajoli; H Morioka; N Trippe; L P Kowalski
Journal: Eur Arch Otorhinolaryngol Date: 1992 Impact factor: 2.503

3. Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Authors: L Vormittag; C Lemaire; D Radonjic; G Kornek; E Selzer
Journal: Strahlenther Onkol Date: 2012-02-10 Impact factor: 3.621

4. Update in cancer chemotherapy: head and neck cancer, Part 2.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1986-11 Impact factor: 1.798

5. Phase II study of tallysomycin S10b in patients with advanced head and neck cancer.

Authors: C Nicaise; W K Hong; W Dimery; J Usakewicz; M Rozencweig; I Krakoff
Journal: Invest New Drugs Date: 1990-08 Impact factor: 3.850

6. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.

Authors: J Martinez-Trufero; D Isla; J C Adansa; A Irigoyen; R Hitt; I Gil-Arnaiz; J Lambea; M J Lecumberri; J J Cruz
Journal: Br J Cancer Date: 2010-05-18 Impact factor: 7.640

Review 7. Current role of chemotherapy in head and neck cancer.

Authors: J S Tobias
Journal: Drugs Date: 1992-03 Impact factor: 9.546

8. Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study.

Authors: J Jassem; F Gyergyay; S Kerpel-Fronius; T Nagykálnai; J Baumöhl; J Verweij; L Vuletic; Z Mechl; M Drozd-Lula; S Jelic
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

9. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial.

Authors: S M Lippman; J F Kessler; M Al-Sarraf; D S Alberts; L M Itri; D Mattox; D D Von Hoff; L Loescher; F L Meyskens
Journal: Invest New Drugs Date: 1988-04 Impact factor: 3.850

10. A phase II trial of diaziquone in patients with head and neck cancer.

Authors: F Muñiz; E Vélez-García; J A Neidhart; J F Bender; M Becker; A J Grillo-Lopez
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333